載入...
Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report
Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervical lymph node swelling. Computed tomography reveale...
Na minha lista:
| 發表在: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8161847/ https://ncbi.nlm.nih.gov/pubmed/34064158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28030180 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|